Doxazosin Tablets, USP 4 mg
Unichem is recalling Doxazosin Tablets 4 mg (NDC 29300-353-10) due to incorrect tablet imprinting that may cause medication errors.
Stop using this medication and contact your pharmacy or healthcare provider immediately to verify your bottle's imprint and obtain a correctly labeled replacement.
Why it was recalled
Unichem Pharmaceuticals is recalling Doxazosin Tablets, USP, 4 mg (NDC 29300-353-10, 1000 tablets per bottle) distributed nationwide because some tablets are imprinted with incorrect identification markings, creating a risk of medication errors. Affected bottles were manufactured by Unichem Laboratories Limited in Goa, India.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 Tower Center Boulevard, Suite 2200, East Brunswick, NJ 08816 USA, manufactured by Unichem Laboratories Limited, Plot Number 15 to 18, Pilerne Industrial Estate, Pilerne, Bardez, Goa (India) 403511, NDC 29300-353-10.
- Recall #
- D-0306-2026
Where it was sold
Distributed nationwide.
Official source
Other recent recalls from Unichem Pharmaceuticals USA Inc.
Editorial summary by Recall Canary · last updated 2026-04-27 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification